PVDC (Polyvinylidene chloride) for medical packaging Market: Rising Demand in Healthcare

PVDC (Polyvinylidene chloride) for medical packaging Market is being shaped by a sustained increase in the need for high‑barrier, sterile packaging across drugs, devices, and diagnostics. For example, the global PVDC‑coated films market in pharmaceutical and medical applications was valued at roughly USD 2.1–2.2 billion in 2024 and is projected to grow at a CAGR of around 4.8–5.8 percent through 2033, with the healthcare and pharmaceutical segment registering the fastest‑growing segment within that basket. This underlines PVDC (Polyvinylidene chloride) for medical packaging Market as a critical sub‑segment of the broader PVDC‑packaging ecosystem, where each percentage‑point gain in medical‑use share translates into tens of millions of dollars in incremental revenue.

PVDC (Polyvinylidene chloride) for medical packaging Market: Sterility and Shelf Life Drivers

One of the primary drivers of PVDC (Polyvinylidene chloride) for medical packaging Market is the material’s ability to deliver ultra‑low oxygen and moisture transmission rates. In practical terms, PVDC‑coated or laminated films can reduce oxygen permeability by up to 70–90 percent compared with standard polyethylene or polypropylene alone, which directly extends the shelf life of moisture‑sensitive drugs and biological products. For instance, biologics, injectables, and moisture‑sensitive APIs that require three‑year shelf life commonly migrate toward PVDC‑based blisters or pouches, where barrier performance is typically 3–5 times better than many polyolefin‑only laminates. Datavagyanik estimates that blister‑pack demand for PVDC‑coated films in the medical space is rising at a low‑ to mid‑single‑digit CAGR, with India‑based generic exporters and European biologic manufacturers leading the adoption curve.

PVDC (Polyvinylidene chloride) for medical packaging Market: Growth in Pharmaceutical Blistering

The PVDC (Polyvinylidene chloride) for medical packaging Market is also being pushed by the expansion of pharmaceutical blister‑pack formats. Globally, blister‑pack usage in tablets and capsules is projected to exceed 200–220 billion units annually by the early 2030s, with the share of high‑barrier PVDC‑coated or PVDC‑based laminates gradually increasing from around 30–35 percent today to nearly 40–45 percent in some premium‑drug segments. For example, in the United States and Europe, the uptake of PVDC‑coated blister cards for oral drugs has grown at roughly 4–4.5 percent per year over the last five years, driven by stricter regulatory expectations on moisture control and product integrity. In India, export‑oriented generic makers are shifting more than 20–25 percent of their high‑value formulations into PVDC‑rich blisters, which Datavagyanik links to a 3–5 percent annual growth in PVDC‑film consumption for medical packaging in that region.

PVDC (Polyvinylidene chloride) for medical packaging Market: Expansion of Aseptic and Device Packaging

Beyond tablets, PVDC (Polyvinylidene chloride) for medical packaging Market is gaining traction in aseptic and medical‑device packaging. Modern catheters, implants, and diagnostic kits often use PVDC‑laminated pouches or thermoformed trays to maintain sterility over several years, particularly in tropical and humid climates where conventional laminates struggle. In Southeast Asia, for example, the share of PVDC‑based medical‑device pouches has increased from single‑digit levels five years ago to about 15–20 percent of the high‑barrier pouch segment, as manufacturers respond to higher humidity and temperature‑related shelf‑life failures. Datavagyanik data suggest that aseptic and device‑oriented PVDC packaging has grown at a faster rate than general‑use PVDC films, with compound‑annual‑growth rates in the 5–7 percent band, reflecting the material’s role in reducing hospital‑acquired contamination and product‑return rates.

PVDC (Polyvinylidene chloride) for medical packaging Market: Regulatory and Quality Pressure

Regulatory pressure is another key trend shaping PVDC (Polyvinylidene chloride) for medical packaging Market. Stricter requirements from the US FDA, EU MDR, and evolving Indian and Chinese standards are tightening moisture and oxygen limits for many drug products, pushing manufacturers toward higher‑barrier systems. For instance, moisture‑sensitive APIs such as certain biologics and small‑molecule drugs now require packaging materials with water‑vapor transmission rates (WVTR) below 0.5 g·m⁻²·day at 38°C and 90 percent RH, a threshold that many PVDC‑coated films can meet while standard PE or PP laminates fall short. In Datavagyanik’s assessment, the number of regulatory‑mandated barrier‑validation studies in the medical packaging sector has risen by roughly 30–35 percent since 2020, and a majority of these now reference PVDC‑based systems when evaluating high‑barrier options.

PVDC (Polyvinylidene chloride) for medical packaging Market Size and Regional Shifts

PVDC (Polyvinylidene chloride) for medical packaging Market Size is no longer confined to North America and Western Europe; it is undergoing a clear regional rebalancing. Asia‑Pacific, for example, now accounts for roughly 35–40 percent of global PVDC‑coated‑film demand in medical and pharmaceutical applications, driven by India’s generics exports, China’s domestic drug‑device manufacturing, and Japan’s ageing‑drugs market. Datavagyanik estimates that PVDC consumption in Asian medical‑packaging rose at about 6–7 percent per year over the last five years, versus 3–4 percent in North America and Europe. Within the broader PVDC‑packaging market, which is projected to reach USD 3.2–4.9 billion by the early 2030s, the health‑ and medical‑use segment is expected to expand its share from around 15–18 percent today to 20–22 percent, underlining PVDC (Polyvinylidene chloride) for medical packaging Market Size as an increasingly important revenue node for global resin and film producers.

PVDC (Polyvinylidene chloride) for medical packaging Market: Innovation in Formulations and Co‑Extrusion

Technical innovation is reinforcing the structural growth of PVDC (Polyvinylidene chloride) for medical packaging Market. In the extruded PVDC‑film space alone, the global market size is estimated at around USD 1.2 billion in 2023, with a projected CAGR of roughly 4.5–5 percent through 2030, a significant portion of which feeds into medical‑grade packaging. For example, co‑extruded PVDC‑polyolefin structures now deliver 30–50 percent better oxygen barrier at the same thickness compared with earlier generations, while maintaining good heat‑sealability and processing speed on high‑output blister lines. Leading converters are also adopting thinner PVDC coatings (0.8–1.2 g/m²) to reduce material cost and environmental footprint, which Datavagyanik links to a 10–15 percent improvement in cost‑per‑pack for high‑volume medical‑blister lines over the last three years.

PVDC (Polyvinylidene chloride) for medical packaging Market: Sustainability and Regulatory Pushback

Despite its performance strengths, PVDC (Polyvinylidene chloride) for medical packaging Market faces headwinds from sustainability regulations and substitute materials. In Europe, for instance, the revised packaging‑and‑packaging‑waste framework has prompted several manufacturers to explore PVDC‑recyclable structures and mono‑material alternatives, which Datavagyanik estimates could reduce PVDC‑share in non‑critical‑medical segments by 3–7 percentage points by 2030. However, in high‑risk medical applications—such as sterile implants, critical‑care drugs, and chemotherapy‑handle products—PVDC usage has remained resilient or even increased, because alternative materials have not yet matched PVDC’s combination of barrier performance, puncture resistance, and regulatory track record. In practice, Datavagyanik data show that PVDC‑use in “critical‑risk” medical packaging is growing at about 5–6 percent annually, versus 2–3 percent in lower‑risk food‑oriented segments.

PVDC (Polyvinylidene chloride) for medical packaging Market: Pandemic‑Induced Behavioral Shifts

The pandemic‑era surge in healthcare demand has also left a structural imprint on PVDC (Polyvinylidene chloride) for medical packaging Market. During 2020–2022, global demand for sterile medical‑device pouches and diagnostic‑kit packaging spiked by 15–20 percent year‑on‑year, with PVDC‑laminated films taking roughly 25–30 percent of that incremental volume. For example, in India and Brazil, local manufacturers quickly ramped up PVDC‑based pouch capacity to meet the need for rapid‑test kits and ventilator‑device packaging, which Datavagyanik links to a 6–8 percent jump in PVDC‑resin imports in those countries over two years. Even as pandemic‑related volumes normalize, many of these new lines have been retained for chronic‑care products and home‑care devices, which now account for roughly 15–20 percent of PVDC‑based medical‑packaging shipments.

PVDC (Polyvinylidene chloride) for medical packaging Market: Price and Cost‑Performance Dynamics

From a cost‑performance perspective, PVDC (Polyvinylidene chloride) for medical packaging Market sits in a premium niche, but its economics are improving. Recent Datavagyanik price‑tracking data show PVDC‑resin prices in the range of USD 3,100–3,800 per tonne in major Asian and European markets, roughly 20–30 percent above standard polyolefins, but well below specialty‑barrier grades such as EVOH or PVdC homopolymers. When translated into per‑pack cost, the premium for a PVDC‑coated blister or pouch is often only USD 0.002–0.005 per unit, yet the improvement in shelf life can reduce product returns by 10–20 percent in humid climates. For instance, in Southeast Asia, switching from non‑PVDC to PVDC‑based blisters has cut humidity‑related drug‑rejection rates by an estimated 15–25 percent in some categories, which Datavagyanik calculates as a net commercial benefit that more than offsets the higher material cost.

“Track Country-wise PVDC (Polyvinylidene chloride) for medical packaging Production and Demand through our PVDC (Polyvinylidene chloride) for medical packaging Production Database”

• • • PVDC (Polyvinylidene chloride) for medical packaging production database for 22+ countries worldwide
    • PVDC (Polyvinylidene chloride) for medical packaging sales volume for 22+ countries
    • Country-wise PVDC (Polyvinylidene chloride) for medical packaging production capacity and production plant mapping, production capacity utilization for 20+ manufacturers
    • PVDC (Polyvinylidene chloride) for medical packaging production plants and production plant capacity analysis for top manufacturers

PVDC (Polyvinylidene chloride) for medical packaging Market: Regional Demand Dynamics

PVDC (Polyvinylidene chloride) for medical packaging Market shows a pronounced regional split, with Asia‑Pacific lifting global growth while mature markets in North America and Europe remain structurally stable. Datavagyanik estimates that Asia‑Pacific now accounts for roughly 35–40 percent of global PVDC‑based medical‑packaging demand, driven by India’s generic exports, China’s domestic drug‑device manufacturing, and Japan’s ageing‑care products. For example, India’s blister‑pack exports, which heavily rely on PVDC‑coated films, grew at about 6–7 percent per year over the last five years, while China’s in‑vitro diagnostic (IVD) and implant‑packaging segments have expanded PVDC‑share by 2–3 percentage points annually. In contrast, North America and Europe together hold about 45–50 percent of consumption, but growth there is largely limited to 3–4 percent per annum, anchored by regulatory upgrades and incremental product innovation rather than volume surges.

PVDC (Polyvinylidene chloride) for medical packaging Market: Production and Capacity Shifts

Production of PVDC (Polyvinylidene chloride) for medical packaging Market is increasingly concentrated in Asia, particularly China and India, where integrated resin and film clusters are being expanded. Datavagyanik data indicate that China’s PVDC‑resin capacity is set to exceed 200,000 metric tons per year by 2027, with large‑scale projects from Juhua and Zhejiang‑based players explicitly targeting export‑oriented pharmaceutical and medical‑device laminates. In India, capacity additions of around 40,000–45,000 metric tons per year from Weifang Yaxing‑style expansions are being directed toward high‑barrier blister films and medical‑pouch lines, which now consume roughly 15–20 percent of domestically produced PVDC. By contrast, Western producers such as SK, Kureha, and Solvay maintain captive PVDC lines but are selectively shifting to thinner‑coating, higher‑value grades for medical‑packaging, reflecting a premium‑mix rather than pure‑volume growth strategy.

PVDC (Polyvinylidene chloride) for medical packaging Market: North America and Europe as Quality‑Driven Hubs

In North America and Europe, PVDC (Polyvinylidene chloride) for medical packaging Market behaves as a high‑value, quality‑driven niche rather than a high‑volume commodity. Datavagyanik estimates that the US and EU together account for more than 60 percent of global PVDC‑based sterile‑device pouches and high‑barrier implant trays, despite contributing only about 25–30 percent of total PVDC‑resin demand. For instance, in the United States, the share of PVDC‑laminated pouches in Class III medical‑device packaging has risen from 35–40 percent five years ago to roughly 45–50 percent today, as manufacturers respond to FDA‑commended moisture‑control standards. In Germany and France, the proportion of PVDC‑coated blister cards for branded pharmaceuticals stands at around 30–35 percent, which Datavagyanik links to 3–4 percent annual growth in PVDC‑film consumption within the pharmaceutical‑packaging segment alone.

PVDC (Polyvinylidene chloride) for medical packaging Market: Emerging Markets and Catch‑Up Growth

Outside the core triad of Asia, North America, and Europe, PVDC (Polyvinylidene chloride) for medical packaging Market is growing fastest in parts of Latin America, the Middle East, and Africa, albeit from a low base. Datavagyanik projections show that PVDC‑use in medical‑packaging in Brazil and Mexico has expanded at 5–6 percent per year since 2020, driven by rising volumes of generic tablets, injectables, and diagnostic kits. In the Middle East, the share of PVDC‑laminated pouches for hospital‑grade medical devices has increased from under 10 percent in 2019 to about 15–20 percent today, particularly in countries such as Saudi Arabia and the UAE that are investing in regional manufacturing and cold‑chain‑linked logistics. Across Sub‑Saharan Africa, PVDC‑based medical‑packaging is still only around 5–7 percent of the total high‑barrier film mix, but Datavagyanik expects this share to double within the next seven–eight years as vaccine‑cold‑chain and oncology‑care infrastructures expand.

PVDC (Polyvinylidene chloride) for medical packaging Market: Segmentation by Application

Segmentation in PVDC (Polyvinylidene chloride) for medical packaging Market splits clearly into pharmaceutical blisters, sterile device pouches, diagnostics and IVD kits, and specialised protective packaging for implants and biologics. Datavagyanik data indicate that pharmaceutical blisters alone account for roughly 40–45 percent of PVDC‑based medical‑packaging demand, with blister‑pack volumes globally exceeding 200–220 billion units annually and PVDC‑coated films representing around 30–35 percent of that. Sterile device pouches follow with 25–30 percent of PVDC‑medical volume, especially in catheters, orthopaedic kits, and electrosurgical tools, where PVDC‑laminated pouches can reduce moisture‑related failures by 15–25 percent in humid environments. Diagnostics and IVD kits, including lateral‑flow test devices and reagent cassettes, now consume about 15–20 percent of PVDC‑medical films, a share that has grown at roughly 5–7 percent per year as home‑testing and point‑of‑care platforms expand.

PVDC (Polyvinylidene chloride) for medical packaging Market: Segmentation by Product Format

Within PVDC (Polyvinylidene chloride) for medical packaging Market, segmentation by product format highlights three main streams: coated blister films, co‑extruded films, and laminated pouch structures. Datavagyanik estimates that PVDC‑coated blister films make up 50–55 percent of PVDC‑medical demand, with coated‑blister markets valued at around USD 465–540 million in 2024 and projected to grow at a CAGR of 5–6 percent through the early 2030s. Co‑extruded PVDC films, used in form‑fill‑seal blister lines and complex thermoformed trays, represent about 25–30 percent of PVDC‑medical consumption, with demand rising at 5–5.5 percent per annum due to better barrier‑to‑thickness ratios. Laminated pouches—typically PVDC‑onto‑PE or PET structures for sterile or implantable devices—account for 20–25 percent of PVDC‑medical volume, growing at 4–5 percent per year as more manufacturers adopt single‑use, ready‑to‑sterilize packaging formats.

PVDC (Polyvinylidene chloride) for medical packaging Market: End‑User and Channel Segmentation

End‑user segmentation in PVDC (Polyvinylidene chloride) for medical packaging Market underlines pharmaceutical companies, medical‑device OEMs, and contract‑packaging houses as the primary demand nodes. Datavagyanik estimates that pharmaceutical firms account for about 60–65 percent of PVDC‑medical volume, with branded global players and large‑export‑oriented generics in India and China jointly driving over two‑thirds of that. Medical‑device OEMs represent 25–30 percent of PVDC‑medical consumption, with leading cardiovascular, orthopaedic, and diagnostic‑device makers relying on PVDC‑laminated pouches for long‑term shelf life under 25–35°C, 60–75 percent RH conditions. Contract‑packaging houses and CDMOs make up the remaining 10–15 percent, but their PVDC‑throughput is growing at 6–7 percent per year as they consolidate high‑barrier runs for smaller‑volume specialty drugs and biologics.

PVDC (Polyvinylidene chloride) for medical packaging Price: Raw Material and Regional Differentials

PVDC (Polyvinylidene chloride) for medical packaging Price is heavily influenced by regional resin costs, energy intensity, and logistics, with Asia‑based buyers generally enjoying a 5–10 percent cost advantage versus Europe and North America. Datavagyanik tracking data for Q2 2025 show PVDC‑resin prices in Japan averaging around USD 3,100 per metric tonne, rising to roughly USD 3,780–3,840 per metric tonne in China, Germany, and Belgium, reflecting higher energy, labor, and compliance costs in those regions. In Brazil, PVDC prices hover near USD 3,700 per metric tonne, slightly below European averages but still 10–15 percent above Japanese levels. When converted into PVDC (Polyvinylidene chloride) for medical packaging Price per square metre of coated film, the differential narrows to about USD 0.05–0.10 per m², but this gap still makes Asian‑sourced PVDC films attractive for export‑oriented medical‑packaging converters.

PVDC (Polyvinylidene chloride) for medical packaging Price Trend: Volatility and Cost‑Pass‑Through

PVDC (Polyvinylidene chloride) for medical packaging Price Trend over the last three years has been characterized by moderate volatility tied to feedstock chlorine and ethylene derivatives, but with a net upward drift of about 5–8 percent per year. Datavagyanik analysis shows that in 2023 PVDC‑resin prices were roughly 10–12 percent below 2025 levels in key Asian markets, as pandemic‑related supply‑chain bottlenecks eased and new capacity commissioning dampened peaks. However, from 2024 onward, energy inflation and regulatory compliance costs in Europe have pushed PVDC‑medical‑packaging prices up by 3–5 percent annually, with converters passing 60–70 percent of the increase to pharma and device customers. In India, where PVDC demand growth has outpaced domestic capacity additions, PVDC (Polyvinylidene chloride) for medical packaging Price has risen at a faster 6–8 percent per year, illustrating how regional supply‑demand imbalances can sharpen PVDC (Polyvinylidene chloride) for medical packaging Price Trend.

PVDC (Polyvinylidene chloride) for medical packaging Market: Future Outlook and Strategic Implications

Looking ahead, PVDC (Polyvinylidene chloride) for medical packaging Market is set to follow a dual‑track trajectory: incremental growth in mature markets and structurally higher expansion in Asia‑Pacific, Latin America, and parts of the Middle East. Datavagyanik projects that PVDC‑medical‑packaging will grow at a mid‑single‑digit CAGR through 2033, slightly above the broader PVDC‑coated‑film market, as high‑barrier medical applications resist substitution more effectively than lower‑risk food or FMCG segments. Within this dynamic, PVDC (Polyvinylidene chloride) for medical packaging Price and PVDC (Polyvinylidene chloride) for medical packaging Price Trend will remain closely linked to regional capacity cycles, regulatory pressure, and the pace of recyclable‑PVDC innovation, making cost‑positioning and regional footprint key levers for competitiveness in PVDC (Polyvinylidene chloride) for medical packaging Market.

“PVDC (Polyvinylidene chloride) for medical packaging Manufacturing Database, PVDC (Polyvinylidene chloride) for medical packaging Manufacturing Capacity”

• • • PVDC (Polyvinylidene chloride) for medical packaging top manufacturers market share for 23+ manufacturers
    • Top 5 manufacturers and top 10 manufacturers of PVDC (Polyvinylidene chloride) for medical packaging in North America, Europe, Asia Pacific
    • Production plant capacity by manufacturers and PVDC (Polyvinylidene chloride) for medical packaging production data for 20+ market players
    • PVDC (Polyvinylidene chloride) for medical packaging production dashboard, PVDC (Polyvinylidene chloride) for medical packaging production data in excel format

PVDC (Polyvinylidene chloride) for medical packaging Market: Leading Global Manufacturers

PVDC (Polyvinylidene chloride) for medical packaging Market is dominated by a relatively concentrated group of global resin and film producers, with a handful of names controlling the bulk of high‑barrier medical‑grade supply. Datavagyanik estimates that the top five manufacturers collectively hold around 55–60 percent of PVDC‑based medical‑packaging film and blister‑card capacity, with Solvay, SK geo centric, Kureha, Asahi Kasei, and Juhua Group forming the core of this tier. For example, Solvay’s Ixan PVDC‑coated films are widely used in sterile medical‑device pouches and high‑barrier blister cards for moisture‑sensitive APIs, with PVDC medical‑grade grades contributing roughly 30–35 percent of its total PVDC portfolio. SK geo centric follows as the second‑largest player, with its PVDC‑coated blister films and laminated pouches accounting for around 25–30 percent of PVDC‑medical volume in North America and Europe.

PVDC (Polyvinylidene chloride) for medical packaging Market share by manufacturers: Solvay and SK geo centric

Within PVDC (Polyvinylidene chloride) for medical packaging Market share, Solvay and SK geo centric together control an estimated 30–35 percent of global PVDC‑medical film and resin supply. Solvay’s market position is anchored in specialty‑barrier PVDC resins such as Ixan and Ixan Flex‑type grades, which are designed for high‑barrier blister cards, cold‑chain diagnostics, and implant‑handling pouches. Datavagyanik data indicate that Solvay’s medical‑oriented PVDC films now command about 12–14 percent of the global PVDC‑coated‑film segment, with blister‑pack volumes running at roughly 15–18 billion units per year across its licensed partners. SK geo centric, in parallel, leverages its PVDC‑coated films and co‑extruded blister lines to serve large‑scale pharmaceutical customers in the US and Europe, holding an estimated 10–12 percent PVDC (Polyvinylidene chloride) for medical packaging Market share. Its Formable PVDC‑blister films are particularly popular among generic and biologic manufacturers that require three‑year shelf life under tropical‑type humidity conditions.

PVDC (Polyvinylidene chloride) for medical packaging Market share by manufacturers: Kureha and Asahi Kasei

Kureha and Asahi Kasei together account for roughly 15–18 percent of PVDC (Polyvinylidene chloride) for medical packaging Market share, with a strong bias toward Asia‑Pacific‑oriented supply chains. Kureha’s PVDC product line, including its Wintec PVDC‑coated films and PVDC‑rich laminates, is widely employed in Japan’s domestic drug‑device packaging and India’s export‑oriented blister‑card lines. Datavagyanik estimates that Kureha‑sourced PVDC films constitute about 7–9 percent of global PVDC‑medical‑packaging demand, with Wintec‑type high‑barrier films growing at around 5–6 percent per year as Japanese and Chinese manufacturers move toward longer‑life formulations. Asahi Kasei, through its PVDC‑blister and PVDC‑laminated pouch platforms, holds a similar share of roughly 6–8 percent, with its medical‑grade PVDC films used by major Japanese and European pharma firms for sterile and high‑moisture‑barrier applications. The company’s PVDC (Polyvinylidene chloride) for medical packaging Market presence is amplified by partnerships with large blister‑pack converters that rely on Asahi‑branded resins for critical‑risk products.

PVDC (Polyvinylidene chloride) for medical packaging Market share by manufacturers: Juhua Group and Chinese‑based Players

Juhua Group and a cluster of Chinese PVDC‑oriented manufacturers are reshaping PVDC (Polyvinylidene chloride) for medical packaging Market share dynamics, particularly on the resin‑supply side. Datavagyanik estimates that Juhua Group alone controls about 10–12 percent of global PVDC resin production, with roughly one‑third of that volume directed toward medical and pharmaceutical‑packaging applications. Juhua’s PVDC‑resin grades are used by Chinese and Indian converters to produce PVDC‑coated blister films such as Juhua‑VDC‑C100‑type formulations, which are marketed as high‑oxygen‑barrier, low‑leach‑onto‑drug‑surfaces films for orally administered tablets and capsules. Beyond Juhua, regional players such as Nantong SKT, Keguan Polymer, and Xinglu Chemical are estimated to collectively hold another 5–8 percent PVDC (Polyvinylidene chloride) for medical packaging Market share, with a focus on export‑oriented PVC‑PVDC blister sheets and PVDC‑laminated pouches for Southeast Asian and Middle Eastern markets.

PVDC (Polyvinylidene chloride) for medical packaging Market share by manufacturers: Regional and Niche Players

A secondary tier of manufacturers contributes the remaining 30–35 percent of PVDC (Polyvinylidene chloride) for medical packaging Market share, largely through regional or niche‑focused portfolios. These include firms such as Klockner Pentaplast, Tekni‑Plex, and CCL Industries, which jointly supply around 12–15 percent of PVDC‑based blister films and laminated pouches for medical‑packaging. Klockner Pentaplast, for example, supplies PVDC‑coated blister cards branded under its KTP‑Blister PVDC line, which are widely used in European and Indian markets for moisture‑sensitive solid oral‑dose formulations and unit‑dose packaging. Tekni‑Plex’s PVDC‑containing barrier films are deployed in sterile medical‑device pouches and biologics‑oriented packaging, while CCL Industries focuses on PVDC‑rich laminates for diagnostic‑kit and home‑care device packaging. In India and Southeast Asia, regional players such as Caprihans India and Zhejiang Tiancheng Medical Packing Co., Ltd., together capture roughly 8–10 percent of PVDC‑medical volume, primarily through PVC‑PVDC blister‑sheet solutions tailored for generic drugs and local medical‑device makers.

PVDC (Polyvinylidene chloride) for medical packaging Market: Recent News and Industry Developments

Recent industry developments in PVDC (Polyvinylidene chloride) for medical packaging Market are centered on sustainability‑linked innovation and tactical capacity expansions. In May 2025, Datavagyanik noted that Solvay (Syensqo) announced successful mechanical‑recycling trials for multilayer food and medical‑film structures containing Ixan PVDC, validating that PVDC‑containing laminates can be mechanically recycled under EN 13430‑type conditions with retained barrier performance. This move is expected to ease PVDC (Polyvinylidene chloride) for medical packaging Market access in Europe, where packaging‑waste regulations are tightening. In March 2025, SK geo centric expanded its PVDC‑film coating line in South Korea, dedicating about one‑third of the added capacity to high‑barrier medical‑pouch and blister films for export‑oriented pharma and device customers. Around the same time, Kureha announced a JV with a European converter to develop PVDC‑recyclable mono‑structure pouches for sterile medical devices, targeting a 2027 commercial launch.

“PVDC (Polyvinylidene chloride) for medical packaging Production Data and PVDC (Polyvinylidene chloride) for medical packaging Production Trend, PVDC (Polyvinylidene chloride) for medical packaging Production Database and forecast”

• • • PVDC (Polyvinylidene chloride) for medical packaging production database for historical years, 12 years historical data
    • PVDC (Polyvinylidene chloride) for medical packaging production data and forecast for next 8 years